Hepatocyte Nuclear Factor 1β Suppresses Canonical Wnt Signaling Through Transcriptional Repression of Lymphoid Enhancer-binding Factor 1
Overview
Affiliations
Hepatocyte nuclear factor-1β (HNF-1β) is a tissue-specific transcription factor that is required for normal kidney development and renal epithelial differentiation. Mutations of HNF-1β produce congenital kidney abnormalities and inherited renal tubulopathies. Here, we show that ablation of HNF-1β in mIMCD3 renal epithelial cells results in activation of β-catenin and increased expression of lymphoid enhancer-binding factor 1 (LEF1), a downstream effector in the canonical Wnt signaling pathway. Increased expression and nuclear localization of LEF1 are also observed in cystic kidneys from Hnf1b mutant mice. Expression of dominant-negative mutant HNF-1β in mIMCD3 cells produces hyperresponsiveness to exogenous Wnt ligands, which is inhibited by siRNA-mediated knockdown of Lef1. WT HNF-1β binds to two evolutionarily conserved sites located 94 and 30 kb from the mouse Lef1 promoter. Ablation of HNF-1β decreases H3K27 trimethylation repressive marks and increases β-catenin occupancy at a site 4 kb upstream to Lef1. Mechanistically, WT HNF-1β recruits the polycomb-repressive complex 2 that catalyzes H3K27 trimethylation. Deletion of the β-catenin-binding domain of LEF1 in HNF-1β-deficient cells abolishes the increase in Lef1 transcription and decreases the expression of downstream Wnt target genes. The canonical Wnt target gene, Axin2, is also a direct transcriptional target of HNF-1β through binding to negative regulatory elements in the gene promoter. These findings demonstrate that HNF-1β regulates canonical Wnt target genes through long-range effects on histone methylation at Wnt enhancers and reveal a new mode of active transcriptional repression by HNF-1β.
Jankowski J, Lee H, Liu C, Wilflingseder J, Hennighausen L Commun Biol. 2024; 7(1):1142.
PMID: 39277686 PMC: 11401919. DOI: 10.1038/s42003-024-06855-6.
Bantounas I, Rooney K, Lopes F, Tengku F, Woods S, Zeef L Stem Cell Reports. 2024; 19(6):859-876.
PMID: 38788724 PMC: 11297557. DOI: 10.1016/j.stemcr.2024.04.011.
Jankowski J, Lee H, Liu C, Wilflingseder J, Hennighausen L Res Sq. 2024; .
PMID: 38712042 PMC: 11071613. DOI: 10.21203/rs.3.rs-4188774/v1.
Ng-Blichfeldt J, Stewart B, Clatworthy M, Williams J, Roper K Dev Cell. 2024; 59(5):595-612.e8.
PMID: 38340720 PMC: 7616043. DOI: 10.1016/j.devcel.2024.01.011.
Wu H, Tang X, Wang Y, Wang N, Chen Q, Xie J Stem Cell Res Ther. 2022; 13(1):218.
PMID: 35619172 PMC: 9137216. DOI: 10.1186/s13287-022-02890-4.